Early in the COVID-19 pandemic, an area of the SARS-CoV-2 spike protein was discovered to be a key target for virus-neutralizing antibodies. Scientists using the Advanced Light Source (ALS) have found a second key “site of vulnerability” in that protein, which could help in future vaccine design. https://als.lbl.gov/researchers-set-sights-on-another-covid-19-target/
January 2019 – July 2022
